Newgen BiopharmaNEWG
13F holders, Q2 2026 (June 30)1holders
$0.00avg. 13F price*
At the end of Q2 2026, 1 institutions reported holding Newgen Biopharma Corp. (NEWG) in their 13F filings. The largest holder was Vermillion Wealth Management, Inc. ($0).
- Company
- Newgen Biopharma Corp.
- CUSIP
- 65137B104
- Latest filing quarter
- Q2 2026
Total Exit/New Position Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $0 |
| Exits | 0 | $0 |
Ownership 1 holders
| Vermillion Wealth Management, Inc. | 0.00% | New | 24,350 | $0 |
"% of holder's portfolio" is NEWG's weight in each manager's 13F, not the share of Newgen Biopharma Corp. the manager owns.